These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32828317)

  • 1. Phosphofructokinase-M inhibits cell growth via modulating the FOXO3 pathway in renal cell carcinoma cells.
    Chen Y; Yu Q; Duan X; Wu W; Zeng G
    Biochem Biophys Res Commun; 2020 Sep; 530(1):67-74. PubMed ID: 32828317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
    Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
    Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting
    Meng L; Xing Z; Guo Z; Qiu Y; Liu Z
    Aging (Albany NY); 2021 Mar; 13(7):9613-9626. PubMed ID: 33742606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
    Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
    Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma.
    Min X; Zhang X; Li Y; Cao X; Cheng H; Li Y; Li C; Kong Q; Mao Q; Peng P; Ni Y; Li J; Duan Y; Liu L; Ding Z
    Theranostics; 2020; 10(19):8573-8590. PubMed ID: 32754264
    [No Abstract]   [Full Text] [Related]  

  • 12. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
    Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
    Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
    Lin H; Zeng W; Lei Y; Chen D; Nie Z
    Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene.
    Zhu J; Zhu DQ; Zhang Y; Liu QM; Wang PC; Li HZ; Ma X; Zhang X
    J Cell Physiol; 2019 Mar; 234(3):2581-2592. PubMed ID: 30229899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
    Tong Z; Meng X; Wang J; Wang L
    Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
    Jiang H; Shi QQ; Ge LY; Zhuang QF; Xue D; Xu HY; He XZ
    Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.
    Chen F; Bai J; Li W; Mei P; Liu H; Li L; Pan Z; Wu Y; Zheng J
    PLoS One; 2013; 8(2):e56241. PubMed ID: 23457532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.